Concepedia

Treatment of Fabry disease with different dosing regimens of agalsidase: Effects on antibody formation and GL-3

Anouk C. Vedder, Frank Breunig, Wilma E. Donker‐Koopman, Kevin Mills, Elisabeth Young, Bryan Winchester, Ineke J. M. ten Berge, J.E.M. Groener, Johannes M. F. G. Aerts, Christoph Wanner,

Molecular Genetics and Metabolism · 2008 · 135 citations · 31 references

DOI

Concepts

References

31

Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease

Christine M. Eng, Nathalie Guffon, William R. Wilcox et al. · New England Journal of Medicine · 2001 · 1.5K citations · Full text

, , +14

Echocardiographic criteria for left ventricular hypertrophy: The Framingham heart study

Daniel Levy, Daniel D. Savage, Robert J. Garrison et al. · The American Journal of Cardiology · 1987 · 808 citations

, , +12

α-Galactosidase A deficiency. Fabry disease

R J Desnick · Medical Entomology and Zoology · 2001 · 581 citations

, , +5

Agalsidase-Beta Therapy for Advanced Fabry Disease

Maryam Banikazemi, Jan Bultas, Stephen Waldek et al. · Annals of Internal Medicine · 2007 · 566 citations

, , +7

SAFETY AND EFFICACY OF RECOMBINANT HUMAN a -GALACTOSIDASE A REPLACEMENT THERAPY IN FABRY'S DISEASE

Michelle Ng, N Athalie G Uffon, W Illiam R. W Ilcox et al. · 2001 · 482 citations

, , +5